专利检索 ap:("Du Pont Pharmaceuticals Company") AND inv:"GARDNER, Daniel, S., IV." 第 1 页

1.

发明公开
N-ADAMANT-1-YL-N'- 4-CHLOROBENZOTHIAZOL-2-YL] UREA USEFUL IN THE TREATMENT OF INFLAMMATION AND AS AN ANTICANCER RADIOSENSITIZING AGENT 审中-公开
标题翻译：的N-金刚烷-1-基 - ¬4氯 - 苯并噻唑-2-基脲FOR USE IN炎症的治疗并作为抗恶性肿瘤药RADIOSENSIBILISIERENDES

公开(公告)号：EP1165531A1

公开(公告)日：2002-01-02

申请号：EP00915010.3

申请日：2000-03-15

申请人： Du Pont Pharmaceuticals Company

发明人： DUNCIA, John, J., V. , GARDNER, Daniel, S., IV. , SANTELLA, Joseph, B., III.

IPC分类号： C07D277/82 , A61K31/428 , A61P29/00 , A61P35/00

CPC分类号： C07D277/82

摘要： This invention relates generally to N-adamant-1-yl-N'-[4-chlorobenzolthiazol-2-yl] urea, pharmaceutical compositions comprising the same, and methods of using the same in the treatment of inflammation and as an anticancer radiosensitizing agent.